Thomas Miller
Geen lopende functies
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Walker H. Colston | M | 63 | 21 jaar | |
| Chris Williams | M | 62 | 16 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Victor Alston | M | 52 | 8 jaar | |
| Alfred Mann | M | 98 | 18 jaar | |
| Atul Bhatnagar | M | 66 | 5 jaar | |
| Matthew Pfeffer | M | 67 | - | |
| Jonathan McGuire | M | 61 | - | |
| Anne-Marie Ripley | F | 54 | 11 jaar | |
| Maik Lankau | M | - | - | |
| Laurent Asscher | M | 53 | 9 jaar | |
| Gail Hamilton | F | 74 | 12 jaar | |
| Jonathan Fram | M | 66 | 12 jaar | |
| Stephen Okland | M | 60 | - | |
| Jon F. Rager | M | 84 | 16 jaar | |
| Tim Jones | M | - | - | |
| Jim R. Smith | M | - | - | |
| Brent Novak | M | 51 | 14 jaar | |
| Brian V. Mech | M | 55 | 16 jaar | |
| Patti Key | F | - | - | |
| Anupam Sahai | M | - | - | |
| Raymond de Graaf | M | 57 | 7 jaar | |
| James Miller | M | - | - | |
| Bob Holmen | M | 60 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 jaar |
| Alan Grahame | M | 71 | 8 jaar | |
| Doug Samuelson | M | 64 | 4 jaar | |
| John Moses | M | 65 | 1 jaar | |
| Cliff Hannel | M | 61 | - | |
| David Edward Anderson | M | 68 | 6 jaar | |
| Robert W. Bass | M | 77 | 7 jaar | |
| Lowell E. Sears | M | 73 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 4 jaar |
| Alexander Pepe | M | 61 | - | |
| Massoud Entekhabi | M | 70 | - | |
| Alan Cuellar Amrod | M | 65 | - | |
| David Jacques | M | 61 | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 34 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Thomas Miller
- Persoonlijk netwerk
